1. Home
  2. RDHL vs UGRO Comparison

RDHL vs UGRO Comparison

Compare RDHL & UGRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RDHL
  • UGRO
  • Stock Information
  • Founded
  • RDHL 2009
  • UGRO 2014
  • Country
  • RDHL Israel
  • UGRO United States
  • Employees
  • RDHL N/A
  • UGRO N/A
  • Industry
  • RDHL Biotechnology: Pharmaceutical Preparations
  • UGRO Industrial Specialties
  • Sector
  • RDHL Health Care
  • UGRO Consumer Discretionary
  • Exchange
  • RDHL Nasdaq
  • UGRO Nasdaq
  • Market Cap
  • RDHL 8.2M
  • UGRO 8.8M
  • IPO Year
  • RDHL N/A
  • UGRO N/A
  • Fundamental
  • Price
  • RDHL $5.85
  • UGRO $0.77
  • Analyst Decision
  • RDHL
  • UGRO Strong Buy
  • Analyst Count
  • RDHL 0
  • UGRO 2
  • Target Price
  • RDHL N/A
  • UGRO $5.63
  • AVG Volume (30 Days)
  • RDHL 11.1K
  • UGRO 131.9K
  • Earning Date
  • RDHL 08-29-2024
  • UGRO 03-26-2025
  • Dividend Yield
  • RDHL N/A
  • UGRO N/A
  • EPS Growth
  • RDHL N/A
  • UGRO N/A
  • EPS
  • RDHL N/A
  • UGRO N/A
  • Revenue
  • RDHL $3,707,000.00
  • UGRO $70,320,066.00
  • Revenue This Year
  • RDHL $224.90
  • UGRO $17.15
  • Revenue Next Year
  • RDHL $82.69
  • UGRO $21.76
  • P/E Ratio
  • RDHL N/A
  • UGRO N/A
  • Revenue Growth
  • RDHL N/A
  • UGRO 12.08
  • 52 Week Low
  • RDHL $5.41
  • UGRO $0.60
  • 52 Week High
  • RDHL $20.28
  • UGRO $2.84
  • Technical
  • Relative Strength Index (RSI)
  • RDHL 40.41
  • UGRO 38.00
  • Support Level
  • RDHL $5.80
  • UGRO $0.70
  • Resistance Level
  • RDHL $6.26
  • UGRO $1.12
  • Average True Range (ATR)
  • RDHL 0.31
  • UGRO 0.12
  • MACD
  • RDHL 0.01
  • UGRO 0.01
  • Stochastic Oscillator
  • RDHL 19.33
  • UGRO 32.56

About RDHL Redhill Biopharma Ltd.

Redhill Biopharma Ltd is a specialty biopharmaceutical company focused on gastrointestinal diseases. The company is focused primarily on the advancement of its development pipeline of clinical-stage therapeutic candidates. The company also commercializes in the U.S. GI-related products, Talicia (omeprazole, amoxicillin, and rifabutin) and Aemcolo (rifamycin). The company's current pipeline consists of five therapeutic candidates, which are Opaganib, RHB-107, RHB-102, RHB-204, and RHB-104, most of which are in clinical development.

About UGRO urban-gro Inc.

Urban-gro Inc is an integrated professional services and construction design-build firm. Its business focuses predominantly on providing fee-based knowledge-based services as well as the value-added reselling of equipment. The company offers value-added architectural, engineering, systems procurement and integration, and construction design-build solutions to customers operating in the controlled environment agriculture (CEA) and industrial and other commercial (Commercial) sectors. It derives revenue predominately from the sale of equipment systems, services, construction design-build, and other various immaterial contracts with customers.

Share on Social Networks: